Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer
Open Access
- 15 July 2009
- journal article
- research article
- Published by Springer Nature in Archiv für Gynäkologie
- Vol. 281 (3) , 505-510
- https://doi.org/10.1007/s00404-009-1175-0
Abstract
The main aim of this study was to show the interest of pelvic posterior exenteration to obtain complete resection of the tumor in case of invasion of the rectum by contiguity in advanced-stage ovarian cancer. The secondary aim was to determine the morbidity of this surgery. It is a multicentric, retrospective study of a series of 41 patients, who underwent posterior pelvectomy for advanced-stage ovarian cancer, over a period of 18 years, from July 1989 to July 2007. The surgery resulted in macroscopically complete resection in 19 patients (46.34%), a residual tumor 2 cm in 3 patients (7.32%). In 34 patients (34/41), digestive continuity with satisfactory anal sphincter function was restored immediately or in the short term. The mean delay to the start of complementary treatment was 36 days. Median overall survival was 33 months. The main aim of surgery for ovarian peritoneal carcinomatosis is to obtain a complete resection. In the case of direct invasion of the rectum by contiguity, when there is no cleavage plane between the uterus and the rectum, pelvic posterior exenteration is an effective method to achieve this objective. Morbidity is relatively high, but acceptable given the poor prognosis of this disease, the improved survival after surgery, and improvements in post-operative quality of life and functions.Keywords
This publication has 20 references indexed in Scilit:
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009
- A statement for extensive primary cytoreductive surgery in advanced ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 2008
- Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: Results and 5-year follow-upGynecologic Oncology, 2007
- Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM)European Journal Of Cancer, 2007
- Une exentération pelvienne postérieure avec anastomose est-elle faisable et justifiée dans le traitement des cancers de l'ovaire à un stade évolué ?Annales de Chirurgie, 2006
- The role of surgery in advanced and recurrent ovarian cancerAnnals of Oncology, 2006
- Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancerGynecologic Oncology, 2005
- Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 TrialJournal of Clinical Oncology, 2005
- EUROCARE-3 summary: cancer survival in Europe at the end of the 20th centuryAnnals of Oncology, 2003
- The role of partial sigmoid colectomy for debulking epithelial ovarian carcinomaGynecologic Oncology, 1991